Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

David Kao

Concepts (358)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
33
2024
2129
5.010
 Why?
Machine Learning
7
2024
442
2.390
 Why?
Stroke Volume
17
2025
592
2.040
 Why?
Methadone
5
2023
91
1.600
 Why?
Adrenergic beta-Antagonists
10
2025
321
1.560
 Why?
Pregnancy Complications, Cardiovascular
5
2022
78
1.530
 Why?
Buprenorphine
3
2023
162
1.420
 Why?
Cardiomyopathies
5
2022
340
1.390
 Why?
Decision Support Systems, Clinical
6
2024
204
1.330
 Why?
United States Food and Drug Administration
5
2024
204
1.270
 Why?
Pharmacogenetics
5
2024
172
1.190
 Why?
Cardiomyopathy, Dilated
9
2025
381
1.170
 Why?
Adverse Drug Reaction Reporting Systems
4
2024
74
1.160
 Why?
Arrhythmias, Cardiac
6
2023
317
1.140
 Why?
Electronic Health Records
7
2024
970
1.080
 Why?
Cytochrome P-450 CYP2C19
4
2024
23
1.030
 Why?
Hospitalization
10
2024
2052
0.960
 Why?
Propanolamines
3
2019
97
0.930
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2024
430
0.900
 Why?
Seasons
1
2024
494
0.770
 Why?
Torsades de Pointes
4
2016
22
0.760
 Why?
Pulmonary Edema
1
2021
106
0.730
 Why?
Humans
83
2025
129144
0.720
 Why?
Coffee
1
2021
15
0.720
 Why?
Telemedicine
3
2020
789
0.710
 Why?
Stroke
2
2021
1070
0.710
 Why?
Pharmacogenomic Testing
4
2022
61
0.690
 Why?
Platelet Aggregation Inhibitors
1
2024
442
0.680
 Why?
Defibrillators, Implantable
2
2021
300
0.670
 Why?
Aged
31
2025
21997
0.670
 Why?
Prosthesis Failure
1
2020
114
0.630
 Why?
Prosthesis-Related Infections
1
2020
75
0.630
 Why?
Mobile Applications
1
2021
160
0.630
 Why?
United States
21
2024
13825
0.620
 Why?
Pacemaker, Artificial
1
2020
110
0.620
 Why?
Spironolactone
1
2019
30
0.620
 Why?
Long QT Syndrome
3
2016
67
0.610
 Why?
Device Removal
1
2020
136
0.610
 Why?
Mineralocorticoid Receptor Antagonists
1
2019
46
0.610
 Why?
Biomedical Research
2
2024
637
0.600
 Why?
Diabetes Mellitus
2
2024
1000
0.600
 Why?
Medical Records
2
2019
170
0.600
 Why?
Coronary Disease
1
2021
385
0.590
 Why?
Mortality
3
2019
307
0.580
 Why?
Retrospective Studies
21
2024
14450
0.580
 Why?
Periodicals as Topic
1
2020
203
0.570
 Why?
Risk Assessment
8
2024
3231
0.560
 Why?
Female
47
2025
68494
0.550
 Why?
Analgesics, Opioid
2
2023
908
0.540
 Why?
Hypertension, Pregnancy-Induced
1
2018
68
0.540
 Why?
Receptors, Transforming Growth Factor beta
1
2017
56
0.530
 Why?
Hospital Records
1
2016
11
0.530
 Why?
Atrial Fibrillation
3
2019
376
0.520
 Why?
Hospital Mortality
6
2024
846
0.520
 Why?
Proteoglycans
1
2017
109
0.520
 Why?
Ventricular Function, Left
5
2025
527
0.510
 Why?
Artificial Intelligence
1
2019
245
0.510
 Why?
Disease Management
1
2020
588
0.500
 Why?
Middle Aged
28
2025
31050
0.490
 Why?
Survival
1
2015
38
0.490
 Why?
Male
39
2025
63456
0.490
 Why?
Tetrazoles
1
2015
38
0.480
 Why?
Biphenyl Compounds
1
2015
60
0.470
 Why?
Muscle Proteins
2
2025
220
0.470
 Why?
Myocardial Infarction
3
2018
1021
0.470
 Why?
Research Design
1
2020
1042
0.450
 Why?
Registries
2
2020
1895
0.440
 Why?
Ventricular Remodeling
3
2025
255
0.440
 Why?
Loperamide
2
2023
11
0.430
 Why?
Myocardium
3
2017
978
0.420
 Why?
Adult
27
2024
35469
0.420
 Why?
Precision Medicine
6
2024
386
0.410
 Why?
Diet
1
2021
1212
0.410
 Why?
Polymorphism, Single Nucleotide
4
2017
2059
0.410
 Why?
Tachycardia, Ventricular
1
2015
167
0.410
 Why?
Legislation, Medical
1
2012
11
0.400
 Why?
Amiodarone
1
2012
24
0.390
 Why?
Quality Improvement
2
2020
1095
0.390
 Why?
Patient Readmission
1
2018
652
0.390
 Why?
Peripartum Period
4
2022
16
0.390
 Why?
Phenotype
5
2025
3071
0.390
 Why?
Anti-Arrhythmia Agents
1
2012
111
0.380
 Why?
Heart Arrest
4
2019
320
0.370
 Why?
Treatment Outcome
10
2025
10192
0.360
 Why?
Catheter Ablation
1
2015
335
0.360
 Why?
Sex Factors
4
2024
1964
0.360
 Why?
Pyrazines
2
2008
87
0.360
 Why?
Postoperative Complications
2
2020
2472
0.350
 Why?
Cardiovascular Diseases
5
2024
2003
0.350
 Why?
Transfusion Reaction
1
2011
43
0.350
 Why?
Forecasting
2
2024
358
0.340
 Why?
Triazoles
2
2008
148
0.340
 Why?
Patient Transfer
1
2012
148
0.340
 Why?
Heart-Assist Devices
1
2016
537
0.340
 Why?
Echocardiography
3
2024
629
0.340
 Why?
Insurance, Health
1
2012
265
0.330
 Why?
Patient Discharge
2
2021
835
0.330
 Why?
Databases, Factual
5
2020
1266
0.320
 Why?
Risk Factors
9
2024
9740
0.320
 Why?
Aged, 80 and over
7
2024
7037
0.320
 Why?
Anemia
1
2011
160
0.320
 Why?
Thiazolidinediones
1
2010
137
0.310
 Why?
Genotype
3
2024
1833
0.310
 Why?
Marketing
1
2008
28
0.310
 Why?
Renal Insufficiency
1
2011
149
0.310
 Why?
Rhabdomyolysis
1
2008
22
0.300
 Why?
Simvastatin
1
2008
60
0.300
 Why?
Length of Stay
4
2024
1120
0.290
 Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2008
46
0.290
 Why?
Heart Ventricles
4
2017
781
0.290
 Why?
Receptors, Adrenergic, beta-1
4
2019
46
0.290
 Why?
Heart Rate
3
2025
802
0.290
 Why?
Electrocardiography
4
2019
608
0.280
 Why?
Proportional Hazards Models
4
2021
1197
0.280
 Why?
Kaplan-Meier Estimate
3
2016
851
0.280
 Why?
Cytochrome P-450 CYP2D6
3
2022
28
0.280
 Why?
Drug Industry
1
2008
106
0.280
 Why?
Practice Patterns, Physicians'
3
2020
1266
0.270
 Why?
Pharmacovigilance
2
2024
21
0.270
 Why?
Emergency Service, Hospital
2
2020
1896
0.260
 Why?
Follow-Up Studies
6
2024
4882
0.260
 Why?
Incidence
5
2024
2635
0.260
 Why?
Elective Surgical Procedures
2
2020
164
0.260
 Why?
Biological Specimen Banks
3
2024
97
0.260
 Why?
Patient Reported Outcome Measures
2
2020
372
0.250
 Why?
Gene Expression Regulation
1
2015
2536
0.240
 Why?
Cause of Death
2
2019
392
0.240
 Why?
Glucose
1
2010
1000
0.230
 Why?
Pandemics
3
2022
1482
0.230
 Why?
Young Adult
9
2022
12385
0.230
 Why?
New York
1
2024
128
0.230
 Why?
Diabetic Cardiomyopathies
1
2024
34
0.230
 Why?
Pregnancy
6
2022
6392
0.220
 Why?
Randomized Controlled Trials as Topic
3
2021
1363
0.220
 Why?
Acute Kidney Injury
2
2008
789
0.220
 Why?
Adolescent
10
2020
20297
0.210
 Why?
Diphenoxylate
1
2023
5
0.210
 Why?
Heart Defects, Congenital
2
2020
757
0.210
 Why?
Nonprescription Drugs
1
2023
66
0.200
 Why?
Medicare
2
2020
706
0.200
 Why?
Prognosis
5
2020
3766
0.200
 Why?
Naltrexone
1
2023
87
0.200
 Why?
Insulin Resistance
1
2010
1165
0.190
 Why?
Time Factors
3
2020
6541
0.180
 Why?
Hypoglycemic Agents
1
2010
1220
0.180
 Why?
Data Interpretation, Statistical
2
2020
336
0.180
 Why?
Speech
1
2021
74
0.180
 Why?
Red Meat
1
2021
17
0.180
 Why?
Smartphone
1
2021
87
0.180
 Why?
Drug Dosage Calculations
1
2020
22
0.180
 Why?
Losartan
1
2020
14
0.180
 Why?
Actigraphy
1
2021
98
0.180
 Why?
Lisinopril
1
2020
14
0.180
 Why?
Wearable Electronic Devices
1
2021
45
0.180
 Why?
Hypertension
2
2020
1242
0.170
 Why?
Protective Factors
1
2021
91
0.170
 Why?
Angioedema
1
2020
16
0.170
 Why?
Cardiac Resynchronization Therapy
1
2021
45
0.170
 Why?
Referral and Consultation
2
2017
726
0.170
 Why?
American Heart Association
2
2019
296
0.170
 Why?
Turner Syndrome
1
2021
51
0.170
 Why?
Milk
1
2021
119
0.170
 Why?
Data Accuracy
1
2020
57
0.170
 Why?
Biological Products
1
2023
200
0.170
 Why?
California
2
2012
400
0.170
 Why?
Software
2
2015
606
0.170
 Why?
Bionics
1
2019
12
0.170
 Why?
Editorial Policies
1
2020
48
0.170
 Why?
Medical Futility
1
2019
23
0.160
 Why?
Medical Informatics
1
2020
99
0.160
 Why?
Medical Record Linkage
1
2020
60
0.160
 Why?
Information Storage and Retrieval
1
2020
108
0.160
 Why?
Drug Overdose
1
2023
322
0.160
 Why?
Prescription Drugs
1
2020
112
0.160
 Why?
Social Determinants of Health
1
2022
220
0.160
 Why?
Drug Prescriptions
1
2021
247
0.150
 Why?
Sitagliptin Phosphate
2
2008
32
0.150
 Why?
Medical Order Entry Systems
1
2019
43
0.150
 Why?
Cohort Studies
3
2021
5408
0.150
 Why?
Tobacco Use
1
2019
61
0.150
 Why?
Child Health Services
1
2020
184
0.150
 Why?
Dose-Response Relationship, Drug
4
2020
2008
0.150
 Why?
Computer Graphics
2
2015
41
0.150
 Why?
Cluster Analysis
1
2019
480
0.150
 Why?
Gene Regulatory Networks
2
2023
280
0.150
 Why?
Receptors, Histamine H2
1
2017
8
0.140
 Why?
Florida
1
2018
93
0.140
 Why?
Advisory Committees
1
2019
216
0.140
 Why?
Prospective Studies
4
2021
7117
0.140
 Why?
Academic Medical Centers
1
2020
474
0.140
 Why?
Dyslipidemias
1
2019
177
0.140
 Why?
Nursing Assessment
1
2017
52
0.130
 Why?
Population Surveillance
1
2020
438
0.130
 Why?
Antihypertensive Agents
1
2020
485
0.130
 Why?
Pressure Ulcer
1
2017
34
0.130
 Why?
Patient Participation
1
2020
414
0.130
 Why?
Cardiology
1
2019
261
0.130
 Why?
Heart Diseases
1
2020
350
0.130
 Why?
Hospitals, Teaching
1
2017
113
0.130
 Why?
Tilidine
1
2016
2
0.130
 Why?
Consensus
1
2019
615
0.130
 Why?
Double-Blind Method
3
2025
1874
0.130
 Why?
Genetic Markers
1
2017
336
0.120
 Why?
Oxycodone
1
2016
42
0.120
 Why?
Databases, Genetic
1
2017
230
0.120
 Why?
Rheumatic Heart Disease
1
2015
4
0.120
 Why?
Sex Distribution
1
2016
359
0.120
 Why?
Rheumatic Fever
1
2015
9
0.120
 Why?
Cholesterol Ester Transfer Proteins
1
2015
18
0.120
 Why?
Angiotensin II Type 1 Receptor Blockers
1
2015
36
0.120
 Why?
Computational Biology
2
2017
596
0.120
 Why?
Gene Expression Profiling
3
2017
1683
0.120
 Why?
Hospitals, Low-Volume
1
2015
22
0.120
 Why?
Naloxone
1
2016
112
0.120
 Why?
Angiotensin II
1
2015
95
0.120
 Why?
Marijuana Use
1
2018
192
0.120
 Why?
Hospitals, High-Volume
1
2015
39
0.120
 Why?
United Kingdom
1
2015
257
0.120
 Why?
Oligonucleotide Array Sequence Analysis
1
2017
755
0.110
 Why?
Percutaneous Coronary Intervention
1
2020
467
0.110
 Why?
Mothers
1
2020
730
0.110
 Why?
Biomarkers
2
2024
3963
0.110
 Why?
Age Factors
2
2019
3140
0.110
 Why?
International Classification of Diseases
1
2015
122
0.110
 Why?
Comorbidity
1
2019
1544
0.110
 Why?
Narcotic Antagonists
1
2015
164
0.110
 Why?
Chronic Disease
2
2020
1714
0.110
 Why?
Gene Expression
2
2017
1463
0.110
 Why?
Cholesterol
1
2015
412
0.100
 Why?
Down-Regulation
1
2015
636
0.100
 Why?
Ventricular Dysfunction, Left
2
2020
385
0.100
 Why?
MicroRNAs
2
2017
676
0.100
 Why?
RNA, Messenger
2
2017
2699
0.100
 Why?
Coronary Artery Disease
1
2019
679
0.100
 Why?
Myocytes, Cardiac
1
2017
499
0.100
 Why?
Federal Government
1
2012
27
0.100
 Why?
Drug Resistance
1
2012
165
0.100
 Why?
Area Under Curve
1
2012
304
0.100
 Why?
Patient Safety
1
2015
285
0.090
 Why?
Genetic Predisposition to Disease
2
2017
2272
0.090
 Why?
Opiate Substitution Treatment
1
2013
136
0.090
 Why?
Colorado
4
2024
4402
0.090
 Why?
Predictive Value of Tests
1
2017
1943
0.090
 Why?
Gastrointestinal Hemorrhage
1
2012
121
0.090
 Why?
Pulmonary Disease, Chronic Obstructive
1
2019
983
0.090
 Why?
Anti-Retroviral Agents
1
2013
231
0.090
 Why?
Pregnancy Outcome
1
2013
389
0.090
 Why?
Survival Rate
1
2015
1869
0.090
 Why?
Bayes Theorem
1
2012
373
0.090
 Why?
Managed Care Programs
2
2022
133
0.090
 Why?
Genome-Wide Association Study
1
2017
1326
0.080
 Why?
Endoscopy, Gastrointestinal
1
2012
219
0.080
 Why?
Delivery of Health Care
1
2017
892
0.080
 Why?
Emergency Medical Services
1
2015
521
0.080
 Why?
Severity of Illness Index
1
2017
2736
0.080
 Why?
Multivariate Analysis
1
2012
1495
0.080
 Why?
Primary Health Care
1
2019
1678
0.070
 Why?
Pharmacogenomic Variants
2
2019
35
0.070
 Why?
Drug Approval
1
2008
87
0.070
 Why?
Vasodilator Agents
1
2010
326
0.070
 Why?
Logistic Models
1
2012
1982
0.070
 Why?
Kidney Function Tests
1
2007
152
0.070
 Why?
Animals
3
2023
35286
0.070
 Why?
Zimbabwe
2
2017
53
0.060
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2008
252
0.060
 Why?
Opioid-Related Disorders
1
2013
483
0.060
 Why?
Drug Therapy, Combination
1
2008
1040
0.060
 Why?
Models, Biological
1
2012
1722
0.060
 Why?
Case-Control Studies
1
2012
3372
0.060
 Why?
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
1
2025
33
0.060
 Why?
Depression
2
2022
1306
0.060
 Why?
Cross-Sectional Studies
3
2022
5044
0.060
 Why?
Psychological Tests
1
2005
134
0.060
 Why?
Osteoporosis, Postmenopausal
1
2004
39
0.060
 Why?
Mandible
1
2004
61
0.060
 Why?
Potassium Channels
1
2025
149
0.060
 Why?
Receptors, Adrenergic
1
2023
34
0.050
 Why?
Drug Administration Schedule
2
2020
767
0.050
 Why?
Cardiovascular Agents
1
2025
156
0.050
 Why?
Algorithms
3
2020
1613
0.050
 Why?
Carcinoembryonic Antigen
1
2002
39
0.050
 Why?
Child
5
2020
20768
0.050
 Why?
Antigens, Differentiation
1
2002
81
0.050
 Why?
Antigens, Bacterial
1
2002
119
0.050
 Why?
Electronic Prescribing
1
2021
3
0.050
 Why?
Cell Adhesion Molecules
1
2002
173
0.040
 Why?
Vitamin K Epoxide Reductases
1
2020
12
0.040
 Why?
Health Services Misuse
1
2020
35
0.040
 Why?
Insurance Claim Reporting
1
2020
22
0.040
 Why?
Antidepressive Agents
1
2022
228
0.040
 Why?
Morbidity
1
2020
299
0.040
 Why?
Antineoplastic Agents
1
2010
2045
0.040
 Why?
Membrane Glycoproteins
1
2002
476
0.040
 Why?
Antigens, Neoplasm
1
2002
308
0.040
 Why?
Antigens, CD
1
2002
487
0.040
 Why?
Grounded Theory
1
2019
34
0.040
 Why?
Metoprolol
1
2019
39
0.040
 Why?
Bias
1
2020
196
0.040
 Why?
Aftercare
1
2020
203
0.040
 Why?
Genomics
1
2024
717
0.040
 Why?
HIV Infections
1
2013
2721
0.040
 Why?
Mice, Transgenic
1
2023
2117
0.040
 Why?
Coronary Angiography
1
2020
305
0.040
 Why?
Delivery of Health Care, Integrated
1
2020
248
0.040
 Why?
Inpatients
1
2021
461
0.030
 Why?
Exercise Test
1
2020
612
0.030
 Why?
Tomography, Emission-Computed, Single-Photon
1
2017
77
0.030
 Why?
Focus Groups
1
2019
450
0.030
 Why?
Socioeconomic Factors
1
2020
1208
0.030
 Why?
Neoplasms
1
2010
2442
0.030
 Why?
Frail Elderly
1
2017
120
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2017
328
0.030
 Why?
Puerperal Disorders
1
2016
30
0.030
 Why?
Metabolic Networks and Pathways
1
2017
177
0.030
 Why?
Physician-Patient Relations
1
2020
538
0.030
 Why?
World Health Organization
1
2016
110
0.030
 Why?
Drug Combinations
1
2016
330
0.030
 Why?
Decision Trees
1
2015
90
0.030
 Why?
Data Mining
1
2015
109
0.030
 Why?
Blood Pressure
1
2020
1736
0.030
 Why?
Biopsy
1
2017
1084
0.030
 Why?
Reproducibility of Results
1
2020
3077
0.030
 Why?
Pediatrics
1
2020
1047
0.030
 Why?
Mass Screening
2
2013
1148
0.020
 Why?
Models, Genetic
1
2015
593
0.020
 Why?
Infant
2
2015
8975
0.020
 Why?
Child, Preschool
2
2015
10456
0.020
 Why?
Anthracyclines
1
2010
49
0.020
 Why?
Trastuzumab
1
2010
100
0.020
 Why?
Angiotensin Receptor Antagonists
1
2010
89
0.020
 Why?
Clinical Trials as Topic
1
2015
1003
0.020
 Why?
Signal Transduction
1
2023
4919
0.020
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2010
198
0.020
 Why?
Program Evaluation
1
2013
872
0.020
 Why?
Apoptosis
1
2017
2491
0.020
 Why?
Injections, Intravenous
1
2007
202
0.020
 Why?
Natriuretic Peptide, Brain
1
2007
99
0.020
 Why?
Ultrasonography
1
2010
712
0.020
 Why?
Infusions, Intravenous
1
2007
399
0.020
 Why?
Mice
1
2023
16905
0.020
 Why?
Creatinine
1
2007
490
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2010
757
0.020
 Why?
Hospitals, University
1
2005
178
0.010
 Why?
Dentists
1
2004
19
0.010
 Why?
Femur Neck
1
2004
60
0.010
 Why?
Antibodies, Monoclonal
1
2010
1363
0.010
 Why?
Bone Diseases, Metabolic
1
2004
57
0.010
 Why?
Absorptiometry, Photon
1
2004
248
0.010
 Why?
Nurses
1
2005
164
0.010
 Why?
Heparan Sulfate Proteoglycans
1
2002
21
0.010
 Why?
Analysis of Variance
1
2004
1288
0.010
 Why?
Bone Density
1
2004
462
0.010
 Why?
HeLa Cells
1
2002
611
0.010
 Why?
Binding Sites
1
2002
1247
0.010
 Why?
Amino Acid Sequence
1
2002
2056
0.010
 Why?
Clinical Competence
1
2005
1013
0.010
 Why?
Molecular Sequence Data
1
2002
2835
0.010
 Why?
Physicians
1
2005
859
0.010
 Why?
Kao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (358) concept(s)
_
Co-Authors Expand Description
See all (88) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)